Impaired Synaptic Plasticity in the mPFC and Anxiety-Like Behaviour in Rats Following Repeated Nitrous Oxide Exposure

[1]  J. Sleigh,et al.  An Electroencephalogram Metric of Temporal Complexity Tracks Psychometric Impairment Caused by Low-dose Nitrous Oxide. , 2020, Anesthesiology.

[2]  H. Cao,et al.  Repeated Nitrous Oxide Exposure Exerts Antidepressant-Like Effects Through Neuronal Nitric Oxide Synthase Activation in the Medial Prefrontal Cortex , 2020, Frontiers in Psychiatry.

[3]  H. Nagase,et al.  A delta opioid receptor agonist, KNT-127, in the prelimbic medial prefrontal cortex attenuates glial glutamate transporter blocker-induced anxiety-like behavior in mice. , 2018, Journal of pharmacological sciences.

[4]  A. Mikulecká,et al.  Chronic MK-801 Application in Adolescence and Early Adulthood: A Spatial Working Memory Deficit in Adult Long-Evans Rats But No Changes in the Hippocampal NMDA Receptor Subunits , 2018, Front. Pharmacol..

[5]  Y. Guan,et al.  Adolescent cocaine exposure induces prolonged synaptic modifications in medial prefrontal cortex of adult rats , 2017, Brain Structure and Function.

[6]  E. Bryson,et al.  Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: A systematic review of the case literature. , 2016, The American journal on addictions.

[7]  J. Ramsey,et al.  Up: The rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use , 2016, Journal of psychopharmacology.

[8]  G. Hsiung,et al.  Nitrous Oxide (N2O)-Induced Acute Psychosis , 2014, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[9]  M. Amani,et al.  Neonatal NMDA receptor blockade alters anxiety- and depression-related behaviors in a sex-dependent manner in mice , 2013, Neuropharmacology.

[10]  T. Vanderah,et al.  The delta opioid receptor , 2013 .

[11]  E. Laboureyras,et al.  A high-dose of fentanyl induced delayed anxiety-like behavior in rats. Prevention by a NMDA receptor antagonist and nitrous oxide (N2O) , 2012, Pharmacology Biochemistry and Behavior.

[12]  M. Maze,et al.  Biologic Effects of Nitrous Oxide: A Mechanistic and Toxicologic Review , 2008, Anesthesiology.

[13]  B. Moghaddam,et al.  Progression of Cellular Adaptations in Medial Prefrontal and Orbitofrontal Cortex in Response to Repeated Amphetamine , 2006, The Journal of Neuroscience.

[14]  M. Spinella.  Relationship between drug use and prefrontal‐associated traits , 2003, Addiction biology.

[15]  J. McNicholas,et al.  Nitrous oxide , 2002, Anaesthesia.

[16]  W. Shen,et al.  Effect of Nitrous Oxide on Excitatory and Inhibitory Synaptic Transmission in Hippocampal Cultures , 1998, The Journal of Neuroscience.

[17]  J. Olney,et al.  Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin , 1998, Nature Medicine.

[18]  M. Gillman,et al.  Clinical role and mechanisms of action of analgesic nitrous oxide. , 1998, The International journal of neuroscience.

[19]  B. van Duijn,et al.  Nitrous Oxide‐induced Enhancement of gamma‐Aminobutyric Acid sub A‐mediated Chloride Currents in Acutely Dissociated Hippocampal Neurons , 1998, Anesthesiology.

[20]  A. Brett.  Myeloneuropathy from Whipped Cream Bulbs Presenting as Conversion Disorder , 1997, The Australian and New Zealand journal of psychiatry.

[21]  O. Stenqvist.  Nitrous oxide kinetics , 1994, Acta anaesthesiologica Scandinavica.

[22]  M. Gillman.  Analgesic (sub anesthetic) nitrous oxide interacts with the endogenous opioid system: a review of the evidence. , 1986, Life sciences.

[23]  W. Mapleson,et al.  Solubility coefficients for inhaled anaesthetics for water, oil and biological media. , 1973, British journal of anaesthesia.

[24]  E. Miller,et al.  An integrative theory of prefrontal cortex function. , 2001, Annual review of neuroscience.